FHTX · Foghorn Therapeutics Inc. · Documents
Market Cap
$286.83M
Shares
59.39M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-24 | — | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-30 | 2026-06-24 | |
| 8-K | 2026-04-21 | — | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2026-03-11 | — | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-01-12 | 2026-01-09 | |
| 8-K | 2025-12-04 | 2025-12-03 | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-07-01 | 2025-06-27 | |
| 8-K | 2025-06-17 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-05-05 | 2025-06-17 | |
| 8-K | 2025-05-01 | 2025-04-25 | |
| 8-K | 2025-04-28 | — | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-02-03 | — | |
| 8-K | 2025-01-24 | 2025-01-23 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-30 | 2024-12-29 | |
| 8-K | 2024-12-16 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-10 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-26 | — | |
| 8-K | 2024-06-03 | — | |
| 8-K | 2024-05-23 | — | |
| 8-K | 2024-05-22 | 2024-05-20 | |
| 8-K | 2024-05-20 | — | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| DEF 14A | 2024-05-03 | 2024-06-26 |
Showing 1–50 of 122 filings
Key facts
CIK
1822462
CUSIP
344174107
13F (30d)
65 filings
65 filers
Visit website
Investor relations